• SchizoDenji@lemm.ee
    link
    fedilink
    English
    arrow-up
    4
    arrow-down
    1
    ·
    1 year ago

    And who decides whether the price is too high or not? It’s just adding a needless middleman who is going to get his cut from the pharma lobby.